FDA Inspection 1068395 — Chartwell Pharmaceuticals Congers, LLC

Chartwell Pharmaceuticals Congers, LLC — FEI 3008897678

The FDA completed an inspection of Chartwell Pharmaceuticals Congers, LLC on September 26, 2018 in Congers, NY. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
September 26, 2018
Fiscal Year
2018
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Congers, NY (United States)